Note: Ingredients listed on restricted chemical lists
EC/CAS
108-95-2
Name of the chemical
Phenol
Concentration
N/A
General Information
Revision date
2018-08-06
Product name
Ozempic (semaglutide) for Injection
1.2.1 Relevant identified uses
Ozempic® is a glucagon-like peptide 1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
supplier name
Novo Nordisk
Icons in SDS
Company Information
company name
Novo Nordisk
Section 2
Classification (GHS-US)
Not classified
2.2 Label elements
GHS-US labeling No labeling applicable
Other hazards which do not result in classification
No additional information available 2.4.
Ingredient(s) with unknown acute toxicity
Not applicable
